KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Receivables (2016 - 2025)

Historic Receivables for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to $219.5 million.

  • Teladoc Health's Receivables fell 181.71% to $219.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $219.5 million, marking a year-over-year decrease of 181.71%. This contributed to the annual value of $224.0 million for FY2024, which is 265.49% down from last year.
  • According to the latest figures from Q3 2025, Teladoc Health's Receivables is $219.5 million, which was down 181.71% from $234.0 million recorded in Q2 2025.
  • In the past 5 years, Teladoc Health's Receivables ranged from a high of $243.2 million in Q1 2025 and a low of $178.1 million during Q3 2021
  • Moreover, its 5-year median value for Receivables was $226.2 million (2022), whereas its average is $218.4 million.
  • Its Receivables has fluctuated over the past 5 years, first soared by 15217.55% in 2021, then crashed by 548.7% in 2024.
  • Teladoc Health's Receivables (Quarter) stood at $190.1 million in 2021, then increased by 23.94% to $235.6 million in 2022, then decreased by 2.37% to $230.1 million in 2023, then decreased by 2.65% to $224.0 million in 2024, then fell by 2.0% to $219.5 million in 2025.
  • Its last three reported values are $219.5 million in Q3 2025, $234.0 million for Q2 2025, and $243.2 million during Q1 2025.